Transcend Alco-foam Hand Sanitizer

Dosage for alcohol varies significantly based on the intended medical use. For Neurolytic Blocks, healthcare providers typically use small volumes (0.5 mL to 2 mL) of dehydrated alcohol injected precisely at the target nerve site. For Topical Antisepsis, a sufficient amount is applied to the skin to wet the area thoroughly before allow it to air dry. Systemic doses for therapeutic purposes (such as treating methanol poisoning in emergency settings) are calculated based on body weight and blood ethanol targets, usually requiring an initial loading dose followed by a maintenance infusion.

Alcohol is generally not recommended for therapeutic use in children unless the benefits outweigh the significant risks of CNS depression and metabolic toxicity. Pediatric exposure most commonly occurs through excipients in liquid medications. Healthcare providers must calculate the total daily alcohol intake from all sources to ensure it does not exceed safety thresholds (typically <5% v/v in medications for children under 6 years old).

Renal Impairment

While the kidneys excrete only a small fraction of alcohol, renal failure can alter the volume of distribution. No specific dose adjustments are standardized, but close monitoring is required.

Hepatic Impairment

Since the liver is the primary site of metabolism, patients with hepatic impairment (cirrhosis or hepatitis) will have significantly reduced clearance of alcohol. Lower doses and extended intervals are necessary to prevent toxicity.

Elderly Patients

Geriatric patients often have a lower percentage of body water, leading to higher blood alcohol concentrations from the same dose compared to younger adults. Increased sensitivity to CNS effects is common.

Medical alcohol is rarely self-administered. For neurolytic procedures, it is administered by a specialist (such as an anesthesiologist) using radiographic guidance. For topical use, ensure the area is clean of organic matter (like blood or dirt) before application. If using a medication that contains alcohol as an excipient, follow the specific instructions for that drug regarding food intake.

Because medical alcohol is typically administered as a one-time procedure or as part of a clinical protocol, missed doses are rare. If a topical application is missed before a procedure, it should be applied immediately before continuing.

Signs of alcohol overdose (toxicity) include severe CNS depression, respiratory distress, hypotension (low blood pressure), hypothermia, and hypoglycemia. In severe cases, it can lead to coma or death. Emergency measures include respiratory support, gastric lavage (if recently ingested), and hemodialysis in extreme cases.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

When used as a medical treatment, common side effects include:

• Injection Site Pain: A sharp, burning sensation during and immediately after neurolytic injection.
• Local Tissue Irritation: Redness or swelling at the site of application.
• Dizziness: A feeling of lightheadedness or unsteadiness, especially if systemic absorption occurs.
• Nausea: A general feeling of stomach upset.

• Paresthesia: Numbness or a 'pins and needles' sensation in the area surrounding a nerve block.
• Headache: Often transient following systemic exposure.
• Skin Dryness: Common with repeated topical use of high-concentration alcohol.

• Post-Injection Neuritis: Inflammation of the nerve that can cause a temporary increase in pain.
• Tissue Necrosis: Death of skin or muscle tissue if the alcohol is injected too superficially or leaks into unintended areas.
• Anaphylaxis: A severe, life-threatening allergic reaction (rare, but possible in patients with alcohol hypersensitivity).

> Warning: Stop using products containing alcohol and call your doctor immediately if you experience any of these:

• Respiratory Depression: Slow, shallow, or difficult breathing.
• Severe Hypotension: Fainting, extreme dizziness, or cold, clammy skin.
• Seizures: Uncontrolled muscle movements or loss of consciousness.
• Vision Changes: Blurred vision or loss of vision (specifically associated with methanol contamination or high-dose systemic toxicity).

Prolonged exposure to alcohol (even as an excipient) can lead to hepatic steatosis (fatty liver), peripheral neuropathy (nerve damage), and cognitive impairment. In the context of neurolytic blocks, long-term effects may include permanent sensory loss or motor weakness in the distribution of the treated nerve.

There are currently no standard FDA Black Box Warnings for dehydrated alcohol injection; however, it is strictly indicated only for use by clinicians experienced in nerve block techniques due to the risk of permanent nerve damage if misplaced.

Report any unusual symptoms to your healthcare provider.

Alcohol is a potent substance that can cause significant harm if used incorrectly. It should only be used for medical purposes under the direct supervision of a healthcare professional.

No FDA black box warnings for Alcohol (Ethanol).

• Allergic Reactions: Patients with a known hypersensitivity to ethanol or any components of the formulation should avoid use. Symptoms of anaphylaxis require emergency intervention.
• Hepatotoxicity: Alcohol is toxic to the liver. Patients with pre-existing liver disease are at much higher risk for toxicity even at lower doses.
• Respiratory Depression: Alcohol can depress the central drive for breathing. This risk is amplified when combined with other CNS depressants like opioids.
• Nerve Damage: In neurolytic procedures, there is a risk of 'off-target' nerve damage, which could lead to permanent paralysis or loss of sensation in unintended areas.

Patients receiving systemic alcohol or frequent neurolytic blocks may require:

• Liver Function Tests (LFTs): To monitor for signs of hepatic strain.
• Blood Glucose: Alcohol can inhibit gluconeogenesis, leading to hypoglycemia (low blood sugar), particularly in diabetic or malnourished patients.
• Neurological Exams: To assess the efficacy and safety of nerve-blocking procedures.

Alcohol significantly impairs motor coordination, reaction time, and judgment. Patients should not drive or operate heavy machinery for at least 24 hours following a neurolytic block or if they are taking medications with high alcohol content.

Consumption of beverage alcohol while undergoing medical treatment with alcohol-containing products can lead to additive toxicity and unpredictable blood levels. This combination should be strictly avoided.

While a single medical procedure does not require tapering, chronic exposure to alcohol (as an excipient) can lead to physical dependence. Sudden discontinuation in such cases may trigger withdrawal symptoms, including tremors, anxiety, and tachycardia (rapid heart rate).

> Important: Discuss all your medical conditions with your healthcare provider before starting Alcohol.

• Disulfiram (Antabuse): Using alcohol with disulfiram causes a severe reaction including flushing, throbbing headache, respiratory difficulty, nausea, and vomiting. This is due to the accumulation of acetaldehyde.
• Metronidazole (Flagyl): Can cause a 'disulfiram-like' reaction. Patients should avoid alcohol during and for 72 hours after metronidazole therapy.

• CNS Depressants (Benzodiazepines, Opioids, Barbiturates): These drugs significantly increase the risk of profound sedation, respiratory depression, and coma when combined with alcohol.
• Oral Hypoglycemics (e.g., Glyburide): Alcohol can potentiate the blood-sugar-lowering effects, leading to severe hypoglycemia.

• NSAIDs (Aspirin, Ibuprofen): Concurrent use increases the risk of gastrointestinal bleeding and gastric mucosal damage.
• Anticoagulants (Warfarin): Alcohol can fluctuate INR levels, making blood thinning effects unpredictable.

• High-Fat Meals: May delay the absorption of orally ingested alcohol but does not change the total amount absorbed.
• Caffeine: May mask the sedative effects of alcohol, leading to a false sense of alertness, but does not reverse the impairment of motor skills.

• Kava Kava / Valerian Root: These supplements have sedative properties that can be dangerously amplified by alcohol.
• St. John's Wort: May increase the metabolism of alcohol or enhance CNS depression.

Alcohol can interfere with several laboratory tests:

• Uric Acid: May cause falsely elevated levels (hyperuricemia).
• Triglycerides: Often acutely elevated after alcohol exposure.
• Cortisol: May interfere with the dexamethasone suppression test.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Alcohol must NEVER be used in the following circumstances:

• Known Hypersensitivity: Any previous severe allergic reaction to ethanol or isopropyl alcohol.
• Disulfiram Therapy: Due to the risk of a life-threatening disulfiram-ethanol reaction.
• Subarachnoid Space: Dehydrated alcohol should not be injected into the subarachnoid space if there is a risk of unintended spinal cord damage.

Healthcare providers will perform a risk-benefit analysis in patients with:

• Severe Hepatic Disease: Due to impaired metabolism.
• Pregnancy: Due to the risk of fetal harm.
• Active Peptic Ulcer Disease: As alcohol can exacerbate gastric irritation.
• History of Alcohol Use Disorder (AUD): As medical use may trigger a relapse.

Patients allergic to one form of alcohol (e.g., ethanol) may exhibit cross-sensitivity to other alcohols (e.g., isopropyl alcohol) or to certain preservatives found in alcohol-based injections.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Alcohol.

Alcohol is a known teratogen (a substance that causes birth defects). According to the FDA, there is no known safe amount of alcohol during pregnancy. Exposure can lead to Fetal Alcohol Spectrum Disorders (FASD), characterized by craniofacial abnormalities, growth retardation, and CNS dysfunction. It should only be used in pregnant women if the clinical need is life-saving and no alternatives exist.

Alcohol passes freely into breast milk, reaching concentrations similar to those in maternal blood. It can affect the infant's sleep patterns and motor development. If a medical procedure involving alcohol is necessary, healthcare providers often recommend 'pumping and discarding' milk for several hours post-exposure.

Safety and effectiveness in pediatric patients have not been established for most therapeutic uses. Children are more susceptible to the toxic effects of alcohol, including hypoglycemia and profound CNS depression. Its use is generally restricted to emergency toxicology (as an antidote) or as a minor excipient in essential medications.

Elderly patients are at an increased risk for adverse effects due to age-related decreases in total body water and hepatic blood flow. There is a significantly higher risk of falls, confusion, and drug-drug interactions in this population. Lower doses are typically recommended.

No specific dose adjustment is required for patients with renal impairment, but they should be monitored for fluid and electrolyte imbalances, as alcohol can have a mild diuretic effect.

In patients with Child-Pugh Class B or C hepatic impairment, alcohol clearance is significantly reduced. Medical use of alcohol in these patients carries a high risk of prolonged CNS depression and hepatic encephalopathy.

> Important: Special populations require individualized medical assessment.

Alcohol acts as a non-specific CNS depressant. Its primary molecular target is the GABA-A receptor complex, where it acts as a positive allosteric modulator, increasing chloride ion influx and hyperpolarizing neurons. It also acts as an antagonist at NMDA glutamate receptors, further reducing neuronal excitability. For neurolytic use, its mechanism is physical: it extracts phospholipids and cholesterol from neuronal membranes, causing immediate protein precipitation and subsequent axonal destruction.

The effects of alcohol are dose-dependent. Low concentrations may cause mild disinhibition, while higher concentrations lead to sensory and motor impairment, respiratory depression, and anesthesia. The duration of effect for a neurolytic block can last for weeks to months, as the body must regenerate the destroyed nerve tissue.

| Parameter | Value |

|---|---|

| Bioavailability | ~100% (Oral); Variable (Topical) |

| Protein Binding | Negligible (<5%) |

| Half-life | Concentration-dependent (Zero-order) |

| Tmax | 30 - 90 minutes (Oral) |

| Metabolism | Hepatic (ADH/ALDH Pathways) |

| Excretion | Renal (2%), Lungs (trace), Fecal (trace) |

• Molecular Formula: C2H6O
• Molecular Weight: 46.07 g/mol
• Solubility: Miscible with water, ether, and chloroform.
• Description: A clear, colorless, flammable liquid with a characteristic odor.

Alcohol is categorized as a Non-Standardized Chemical Allergen [EPC] and an Arteriolar Vasodilator [EPC]. It is often grouped with other CNS depressants or local tissue irritants depending on the clinical application.